Ippei Matsumoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ippei Matsumoto has a total of 611 co-authors. Here are the top co-authors by number of shared publications:
- Yonson Ku
Kobe University, Faculty of Medicine
43 shared publications - Tetsuo Ajiki
Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
40 shared publications - Takumi Fukumoto
Department of Surgery, Kobe University, Japan
35 shared publications Atsushi Takebe
Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Faculty of Medicine, Kindai University, Sakai, Japan
33 shared publicationsMasahiro Kido
33 shared publications- Makoto Shinzeki
Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
29 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (5) , 1292-1299
Video-assisted retroperitoneal debridement for infected retroperitoneal fat necrosis following laparoscopic distal pancreatectomy
Video-assisted retroperitoneal debridement (VARD) is an established and minimally invasive treatment option for infected necrotizing pancreatitis. However, its application in the postoperative setting after pancreatic resection has rarely been described. We report a case of extensive infected retroperitoneal fat necrosis following laparoscopic distal pancreatectomy that was successfully managed using a step-up approach incorporating VARD. An 81-year-old woman underwent laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma of the pancreatic tail. On postoperative day (POD) 7, she developed sudden-onset abdominal pain. Computed tomography (CT) demonstrated enlargement of the remnant pancreas with increased peripancreatic fat stranding. Follow-up CT on POD 9 and 12 revealed progressive enlargement of the fluid collection around the pancreatic stump with rapid extension of inflammatory changes into the retroperitoneal space. Conservative management with fasting and antibiotic therapy resulted in temporary improvement in inflammatory markers. However, extensive infected retroperitoneal fat necrosis developed on POD 38. On POD 43, CT-guided percutaneous catheter drainage failed to achieve adequate source control due to highly viscous necrotic debris, necessitating surgical necrosectomy. An additional drainage tube was placed to establish a retroperitoneal access route, after which VARD was performed on POD 55, with removal of 61 g of necrotic fatty tissue. Inflammatory markers rapidly improved, and the patient was discharged in good condition on POD 102. Infected retroperitoneal fat necrosis after laparoscopic distal pancreatectomy was successfully managed using a step-up strategy incorporating VARD. This case highlights VARD as a minimally invasive therapeutic option for postoperative infected retroperitoneal fat necrosis.
- 1 August 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (5) , 1292-1299
Open AccessVideo-assisted retroperitoneal debridement for infected retroperitoneal fat necrosis following laparoscopic distal pancreatectomy
Video-assisted retroperitoneal debridement (VARD) is an established and minimally invasive treatment option for infected necrotizing pancreatitis. However, its application in the postoperative setting after pancreatic resection has rarely been described. We report a case of extensive infected retroperitoneal fat necrosis following laparoscopic distal pancreatectomy that was successfully managed using a step-up approach incorporating VARD. An 81-year-old woman underwent laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma of the pancreatic tail. On postoperative day (POD) 7, she developed sudden-onset abdominal pain. Computed tomography (CT) demonstrated enlargement of the remnant pancreas with increased peripancreatic fat stranding. Follow-up CT on POD 9 and 12 revealed progressive enlargement of the fluid collection around the pancreatic stump with rapid extension of inflammatory changes into the retroperitoneal space. Conservative management with fasting and antibiotic therapy resulted in temporary improvement in inflammatory markers. However, extensive infected retroperitoneal fat necrosis developed on POD 38. On POD 43, CT-guided percutaneous catheter drainage failed to achieve adequate source control due to highly viscous necrotic debris, necessitating surgical necrosectomy. An additional drainage tube was placed to establish a retroperitoneal access route, after which VARD was performed on POD 55, with removal of 61 g of necrotic fatty tissue. Inflammatory markers rapidly improved, and the patient was discharged in good condition on POD 102. Infected retroperitoneal fat necrosis after laparoscopic distal pancreatectomy was successfully managed using a step-up strategy incorporating VARD. This case highlights VARD as a minimally invasive therapeutic option for postoperative infected retroperitoneal fat necrosis.
- Open Access
- 16 June 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (5) , 1178-1184
Successful management of refractory chylous ascites using a Denver shunt following conversion surgery for unresectable locally advanced pancreatic cancer
We describe a case of refractory chylous ascites (RCA) successfully managed with a Denver shunt (DS) after conversion surgery for unresectable locally advanced pancreatic cancer. A 55-year-old woman developed RCA 6 months after distal pancreatectomy with celiac axis and portal vein resection. Conservative therapy, lymphangiography, and repeated paracentesis were ineffective. After confirming negative cytology, culture, and endotoxin tests, DS placement on postoperative day 425 resulted in rapid resolution of ascites, accompanied by improvement in body weight and hypoalbuminemia. No early major complications were observed after DS placement, and she was discharged safely. Although the shunt was removed 29 months later because of internal jugular vein thrombosis, no reaccumulation of ascites was observed thereafter. The patient remains alive without reaccumulation of ascites or tumor recurrence 60 months after curative resection. Although careful patient selection is essential because of potential complications, DS may serve as an effective salvage option for postoperative RCA when conservative approaches fail.
- 16 June 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (5) , 1178-1184
Open AccessSuccessful management of refractory chylous ascites using a Denver shunt following conversion surgery for unresectable locally advanced pancreatic cancer
We describe a case of refractory chylous ascites (RCA) successfully managed with a Denver shunt (DS) after conversion surgery for unresectable locally advanced pancreatic cancer. A 55-year-old woman developed RCA 6 months after distal pancreatectomy with celiac axis and portal vein resection. Conservative therapy, lymphangiography, and repeated paracentesis were ineffective. After confirming negative cytology, culture, and endotoxin tests, DS placement on postoperative day 425 resulted in rapid resolution of ascites, accompanied by improvement in body weight and hypoalbuminemia. No early major complications were observed after DS placement, and she was discharged safely. Although the shunt was removed 29 months later because of internal jugular vein thrombosis, no reaccumulation of ascites was observed thereafter. The patient remains alive without reaccumulation of ascites or tumor recurrence 60 months after curative resection. Although careful patient selection is essential because of potential complications, DS may serve as an effective salvage option for postoperative RCA when conservative approaches fail.
- Open Access
- 17 April 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
Fulminant disseminated carcinomatosis of the bone marrow from pancreatic mucinous carcinoma with predominant signet ring cell morphology
Disseminated carcinomatosis of the bone marrow (DCBM) is a rare and highly aggressive form of bone metastasis arising from solid tumors, most commonly gastric cancers. DCBM originating from pancreatic cancer is exceedingly rare, with only a few cases reported in the literature. A 62-year-old man presented with back pain, loss of appetite, and weight loss. Laboratory tests revealed anemia and thrombocytopenia. Contrast-enhanced computed tomography revealed a hypovascular mass measuring approximately 10 mm in size in the pancreatic tail. Endoscopic ultrasound-guided fine-needle aspiration confirmed the diagnosis of pancreatic mucinous carcinoma. Laboratory evaluation suggested disseminated intravascular coagulation (DIC). Although no nodular bone metastases were detected on imaging studies, bone marrow biopsy revealed diffuse infiltration by adenocarcinoma predominantly composed of tumor cells with signet ring cell carcinoma morphology, leading to a diagnosis of DCBM from pancreatic mucinous carcinoma. The patient developed a subarachnoid hemorrhage due to severe bleeding tendency, and chemotherapy could not be initiated. The patient died on hospital day 11. To our knowledge, this is the first reported case of DCBM arising from pancreatic mucinous carcinoma with bone marrow metastasis predominantly composed of signet ring cell carcinoma morphology. In patients with pancreatic cancer who present with DIC, particularly mucin-producing tumors such as mucinous carcinoma, the possibility of DCBM should be actively suspected, and early bone marrow aspiration and biopsy should be considered.
- 17 April 2026
- Published by Springer Nature in Clinical Journal of Gastroenterology
Open AccessFulminant disseminated carcinomatosis of the bone marrow from pancreatic mucinous carcinoma with predominant signet ring cell morphology
Disseminated carcinomatosis of the bone marrow (DCBM) is a rare and highly aggressive form of bone metastasis arising from solid tumors, most commonly gastric cancers. DCBM originating from pancreatic cancer is exceedingly rare, with only a few cases reported in the literature. A 62-year-old man presented with back pain, loss of appetite, and weight loss. Laboratory tests revealed anemia and thrombocytopenia. Contrast-enhanced computed tomography revealed a hypovascular mass measuring approximately 10 mm in size in the pancreatic tail. Endoscopic ultrasound-guided fine-needle aspiration confirmed the diagnosis of pancreatic mucinous carcinoma. Laboratory evaluation suggested disseminated intravascular coagulation (DIC). Although no nodular bone metastases were detected on imaging studies, bone marrow biopsy revealed diffuse infiltration by adenocarcinoma predominantly composed of tumor cells with signet ring cell carcinoma morphology, leading to a diagnosis of DCBM from pancreatic mucinous carcinoma. The patient developed a subarachnoid hemorrhage due to severe bleeding tendency, and chemotherapy could not be initiated. The patient died on hospital day 11. To our knowledge, this is the first reported case of DCBM arising from pancreatic mucinous carcinoma with bone marrow metastasis predominantly composed of signet ring cell carcinoma morphology. In patients with pancreatic cancer who present with DIC, particularly mucin-producing tumors such as mucinous carcinoma, the possibility of DCBM should be actively suspected, and early bone marrow aspiration and biopsy should be considered.
- Open Access
- 5 March 2026
- Published by S. Karger AG in Liver Cancer
- p. 1-18
Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling
Introduction: Glycolysis-driven hepatocellular carcinoma (HCC) has been associated with resistance to immune checkpoint inhibitors; however, clinical implementation of glycolysis-targeted therapies remains limited by the reliance on transcriptomic subclassification. Methods: We developed a logistic regression model using clinical and pathological features to predict transcriptome-defined glycolysis subclass (training cohort, n = 113). An integer-based scoring system was derived for bedside application. Model performance was assessed using classification metrics, with external validation in TCGA-LIHC cohort. Imaging correlations were analyzed with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) in a clinical cohort (n = 133) lacking transcriptomic data. In addition, pathology-free LASSO model was also developed using 18F-FDG PET/CT, contrast-enhanced CT/Gd-MRI, and serum biomarkers. Results: The integer logistic model (cutoff ≥3), incorporating serum α-fetoprotein, serum albumin, arterial enhancement pattern, and histopathological phenotypes (macrotrabecular-massive, compact, and pseudoglandular), achieved an area under the receiver operating characteristic curve (AUROC) of 0.905, accuracy of 0.850, and F1 score of 0.80 in the training cohort, with consistent performance across subgroups. External validation using the fully annotated subset of the TCGA-LIHC cohort (n = 70) demonstrated preserved model performance (AUROC = 0.825). When applied to the clinical cohort, predicted glycolysis-enhanced HCCs demonstrated significantly higher 18F-FDG uptake and distinct hepatobiliary phase defect on Gd-EOB-DTPA-enhanced MRI. Patients classified as the glycolysis subclass showed a trend toward shorter overall survival (median 95 months, p = 0.079) and significantly shorter recurrence-free survival (median 14.4 vs. 37.7 months, p = 0.017). Visual 18F-FDG PET positivity was strongly associated with the glycolysis subclass (p < 0.001) and corresponded to a tumor-to-liver uptake ratio ≥1.51. A pathology-free LASSO model using four non-invasive variables demonstrated robust predictive performance (AUROC = 0.893). Elevated glycolytic activity was exploratively correlated with lower CD8+ T-cell infiltration and increased PD-1+CTLA-4+CD8+ T cells. Conclusion: We provide a transcriptomics-independent logistic regression model for identifying glycolysis-enhanced HCC. This approach enables practical metabolic subclassification of HCC using routinely available clinical data. Macrotrabecular-massive and compact histopathological patterns, inhomogeneous arterial hyperenhancement, elevated serum α-fetoprotein levels, and 18F-FDG PET positivity are characteristic features of this subclass and may serve as potential indicators to inform the applicability of glycolysis-targeting therapies.
- 5 March 2026
- Published by S. Karger AG in Liver Cancer
- p. 1-18
Open AccessClinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling
Introduction: Glycolysis-driven hepatocellular carcinoma (HCC) has been associated with resistance to immune checkpoint inhibitors; however, clinical implementation of glycolysis-targeted therapies remains limited by the reliance on transcriptomic subclassification. Methods: We developed a logistic regression model using clinical and pathological features to predict transcriptome-defined glycolysis subclass (training cohort, n = 113). An integer-based scoring system was derived for bedside application. Model performance was assessed using classification metrics, with external validation in TCGA-LIHC cohort. Imaging correlations were analyzed with 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) in a clinical cohort (n = 133) lacking transcriptomic data. In addition, pathology-free LASSO model was also developed using 18F-FDG PET/CT, contrast-enhanced CT/Gd-MRI, and serum biomarkers. Results: The integer logistic model (cutoff ≥3), incorporating serum α-fetoprotein, serum albumin, arterial enhancement pattern, and histopathological phenotypes (macrotrabecular-massive, compact, and pseudoglandular), achieved an area under the receiver operating characteristic curve (AUROC) of 0.905, accuracy of 0.850, and F1 score of 0.80 in the training cohort, with consistent performance across subgroups. External validation using the fully annotated subset of the TCGA-LIHC cohort (n = 70) demonstrated preserved model performance (AUROC = 0.825). When applied to the clinical cohort, predicted glycolysis-enhanced HCCs demonstrated significantly higher 18F-FDG uptake and distinct hepatobiliary phase defect on Gd-EOB-DTPA-enhanced MRI. Patients classified as the glycolysis subclass showed a trend toward shorter overall survival (median 95 months, p = 0.079) and significantly shorter recurrence-free survival (median 14.4 vs. 37.7 months, p = 0.017). Visual 18F-FDG PET positivity was strongly associated with the glycolysis subclass (p < 0.001) and corresponded to a tumor-to-liver uptake ratio ≥1.51. A pathology-free LASSO model using four non-invasive variables demonstrated robust predictive performance (AUROC = 0.893). Elevated glycolytic activity was exploratively correlated with lower CD8+ T-cell infiltration and increased PD-1+CTLA-4+CD8+ T cells. Conclusion: We provide a transcriptomics-independent logistic regression model for identifying glycolysis-enhanced HCC. This approach enables practical metabolic subclassification of HCC using routinely available clinical data. Macrotrabecular-massive and compact histopathological patterns, inhomogeneous arterial hyperenhancement, elevated serum α-fetoprotein levels, and 18F-FDG PET positivity are characteristic features of this subclass and may serve as potential indicators to inform the applicability of glycolysis-targeting therapies.
- 1 January 2026
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 73 (10) , 1155-1161
Metachronous multiple insulinomas in oculo-facio-cardio-dental syndrome harboring a novel BCOR deletion: a case report with review of literature
Oculo-facio-cardio-dental (OFCD) syndrome is a rare X-linked dominant disorder caused by pathogenic variants in the BCOR gene and is characterized by distinctive craniofacial, ocular, cardiac, and dental abnormalities. Although OFCD syndrome is a well-defined developmental disorder, its association with endocrine tumors has not been clearly established. We report a female patient with genetically confirmed OFCD syndrome harboring a novel heterozygous deletion in BCOR who developed metachronous multiple insulinomas. The patient presented with recurrent hypoglycemic episodes, and pancreatic neuroendocrine tumors were detected at different time points, necessitating repeated surgical interventions. Histopathological examination confirmed insulinoma in each resected lesion. Comprehensive clinical and pathological evaluations revealed no features suggestive of other known hereditary insulinoma-associated syndromes, including multiple endocrine neoplasia type 1. Previous reports have described either recurrent insulinoma without genetic confirmation of OFCD syndrome or multiple insulinomas without documented recurrence in genetically confirmed cases. In contrast, the present case uniquely demonstrates metachronous development of multiple insulinomas in association with a novel BCOR deletion. Given the role of BCOR in transcriptional repression and developmental regulation, this case suggests a potential contribution of BCOR dysfunction to pancreatic neuroendocrine tumorigenesis. Our findings expand the phenotypic and genotypic spectrum of OFCD syndrome and underscore the importance of long-term surveillance and further accumulation of cases to clarify tumor predisposition in this rare disorder.
- 1 January 2026
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 73 (10) , 1155-1161
Metachronous multiple insulinomas in oculo-facio-cardio-dental syndrome harboring a novel BCOR deletion: a case report with review of literature
Oculo-facio-cardio-dental (OFCD) syndrome is a rare X-linked dominant disorder caused by pathogenic variants in the BCOR gene and is characterized by distinctive craniofacial, ocular, cardiac, and dental abnormalities. Although OFCD syndrome is a well-defined developmental disorder, its association with endocrine tumors has not been clearly established. We report a female patient with genetically confirmed OFCD syndrome harboring a novel heterozygous deletion in BCOR who developed metachronous multiple insulinomas. The patient presented with recurrent hypoglycemic episodes, and pancreatic neuroendocrine tumors were detected at different time points, necessitating repeated surgical interventions. Histopathological examination confirmed insulinoma in each resected lesion. Comprehensive clinical and pathological evaluations revealed no features suggestive of other known hereditary insulinoma-associated syndromes, including multiple endocrine neoplasia type 1. Previous reports have described either recurrent insulinoma without genetic confirmation of OFCD syndrome or multiple insulinomas without documented recurrence in genetically confirmed cases. In contrast, the present case uniquely demonstrates metachronous development of multiple insulinomas in association with a novel BCOR deletion. Given the role of BCOR in transcriptional repression and developmental regulation, this case suggests a potential contribution of BCOR dysfunction to pancreatic neuroendocrine tumorigenesis. Our findings expand the phenotypic and genotypic spectrum of OFCD syndrome and underscore the importance of long-term surveillance and further accumulation of cases to clarify tumor predisposition in this rare disorder.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2026 (1)
A Rare but Life‐Threatening Complication of Direct Endoscopic Necrosectomy: Tension Pneumoperitoneum With Pneumothorax and Hypercapnia due to Walled‐Off Necrosis Rupture
Endoscopic ultrasonography (EUS)–guided drainage followed by direct endoscopic necrosectomy (DEN) is widely used as a minimally invasive treatment for walled‐off necrosis (WON). While this approach is considered effective and safe, serious complications may occur. We report a case of carbon dioxide (CO 2 )–related tension pneumoperitoneum accompanied by severe hypercapnia during DEN. A 65‐year‐old man with gallstone pancreatitis developed a large WON causing gastric outlet obstruction. He underwent EUS‐guided transgastric drainage with placement of a lumen‐apposing metal stent (LAMS), followed by planned DEN sessions under CO 2 insufflation with propofol sedation. During the second DEN session, the LAMS became dislodged, and subsequent DEN was continued after balloon dilation of the endosonographically created route. During the fourth DEN session, the patient experienced sudden oxygen desaturation. Imaging revealed extensive free air in the abdominal and thoracic cavities, and arterial blood gas analysis showed severe hypercapnia. Emergency exploratory laparotomy revealed disruption of the WON wall with communication into the abdominal cavity. Surgical necrosectomy and abdominal irrigation were performed. The patient recovered uneventfully. This case highlights a rare but potentially serious CO 2 ‐related complication of DEN and underscores the need for meticulous control of intracavitary pressure and close respiratory monitoring during the procedure.
- 1 January 2026
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2026 (1)
Open AccessA Rare but Life‐Threatening Complication of Direct Endoscopic Necrosectomy: Tension Pneumoperitoneum With Pneumothorax and Hypercapnia due to Walled‐Off Necrosis Rupture
Endoscopic ultrasonography (EUS)–guided drainage followed by direct endoscopic necrosectomy (DEN) is widely used as a minimally invasive treatment for walled‐off necrosis (WON). While this approach is considered effective and safe, serious complications may occur. We report a case of carbon dioxide (CO 2 )–related tension pneumoperitoneum accompanied by severe hypercapnia during DEN. A 65‐year‐old man with gallstone pancreatitis developed a large WON causing gastric outlet obstruction. He underwent EUS‐guided transgastric drainage with placement of a lumen‐apposing metal stent (LAMS), followed by planned DEN sessions under CO 2 insufflation with propofol sedation. During the second DEN session, the LAMS became dislodged, and subsequent DEN was continued after balloon dilation of the endosonographically created route. During the fourth DEN session, the patient experienced sudden oxygen desaturation. Imaging revealed extensive free air in the abdominal and thoracic cavities, and arterial blood gas analysis showed severe hypercapnia. Emergency exploratory laparotomy revealed disruption of the WON wall with communication into the abdominal cavity. Surgical necrosectomy and abdominal irrigation were performed. The patient recovered uneventfully. This case highlights a rare but potentially serious CO 2 ‐related complication of DEN and underscores the need for meticulous control of intracavitary pressure and close respiratory monitoring during the procedure.
- Open Access
- 28 November 2025
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (3) , 827-834
Functional Advantage of Central Pancreatectomy Over Distal Pancreatectomy for Benign or Low‐Grade Malignant Tumors: A Comparative Analysis Based on 75‐g Oral Glucose Tolerance Test
Background: Central pancreatectomy (CP) is a function‐preserving procedure for benign or low‐grade malignant lesions in the pancreatic neck or proximal body. However, endocrine function after CP has not been objectively evaluated. Methods: We retrospectively analyzed 123 patients who underwent CP ( n = 38) or distal pancreatectomy (DP; n = 85) for benign or low‐grade malignant tumors. Short‐ and long‐term outcomes were compared between groups. Among 37 patients (CP; n = 12, DP; n = 25) underwent a 75‐g oral glucose tolerance test (OGTT) before and 1 month after surgery to evaluate endocrine function. Results: CP was associated with a higher incidence of postoperative pancreatic fistula than DP (40% vs. 8%; p < 0.001). All CP patients achieved R0 resection with no perioperative mortality or tumor recurrence. The incidence of new‐onset diabetes mellitus was significantly lower after CP than after DP (14.8% vs. 50.9%, p = 0.002). In the DP group, the area under the curve (AUC) for blood glucose (BG) increased postoperatively ( p < 0.001), whereas AUCs for immunoreactive insulin (IRI) and C‐peptide immunoreactivity (CPR) decreased ( p = 0.010 and p = 0.022, respectively). Conversely, the CP group showed preserved endocrine function, with no significant postoperative changes in AUCs for BG ( p = 0.351), IRI ( p = 0.723), or CPR ( p = 0.900). Conclusion: Compared with DP, which has acceptable short‐term outcomes, CP preserves pancreatic endocrine function. In patients with benign or low‐grade malignant pancreatic tumors with expected long‐term survival, CP should be considered over DP to preserve function.
- 28 November 2025
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 10 (3) , 827-834
Open AccessFunctional Advantage of Central Pancreatectomy Over Distal Pancreatectomy for Benign or Low‐Grade Malignant Tumors: A Comparative Analysis Based on 75‐g Oral Glucose Tolerance Test
Background: Central pancreatectomy (CP) is a function‐preserving procedure for benign or low‐grade malignant lesions in the pancreatic neck or proximal body. However, endocrine function after CP has not been objectively evaluated. Methods: We retrospectively analyzed 123 patients who underwent CP ( n = 38) or distal pancreatectomy (DP; n = 85) for benign or low‐grade malignant tumors. Short‐ and long‐term outcomes were compared between groups. Among 37 patients (CP; n = 12, DP; n = 25) underwent a 75‐g oral glucose tolerance test (OGTT) before and 1 month after surgery to evaluate endocrine function. Results: CP was associated with a higher incidence of postoperative pancreatic fistula than DP (40% vs. 8%; p < 0.001). All CP patients achieved R0 resection with no perioperative mortality or tumor recurrence. The incidence of new‐onset diabetes mellitus was significantly lower after CP than after DP (14.8% vs. 50.9%, p = 0.002). In the DP group, the area under the curve (AUC) for blood glucose (BG) increased postoperatively ( p < 0.001), whereas AUCs for immunoreactive insulin (IRI) and C‐peptide immunoreactivity (CPR) decreased ( p = 0.010 and p = 0.022, respectively). Conversely, the CP group showed preserved endocrine function, with no significant postoperative changes in AUCs for BG ( p = 0.351), IRI ( p = 0.723), or CPR ( p = 0.900). Conclusion: Compared with DP, which has acceptable short‐term outcomes, CP preserves pancreatic endocrine function. In patients with benign or low‐grade malignant pancreatic tumors with expected long‐term survival, CP should be considered over DP to preserve function.
- 20 November 2025
- Published by Springer Nature in Surgery Today
- Vol. 56 (5) , 799-806
A comparison of laparoscopic and robotic distal pancreatectomy with spleen and Splenic vessels preservation: an intention-based evaluation in a single-center retrospective study
Purpose To compare the short-term outcomes of robotic distal pancreatectomy (RDP) and laparoscopic distal pancreatectomy (LDP), with a particular focus on the actual completion rates of spleen and splenic vessels preservation preoperatively. Methods Fifty-two RDP and 87 LDP procedures performed between 2014 and 2024 were retrospectively analyzed. Results The operative time was significantly longer for RDP than for LDP (median 407 min vs. 320 min, p < 0.0001), whereas the intraoperative blood loss was significantly lower (median 70 mL vs. 100 mL, p = 0.011). The rate of conversion to open surgery was also lower for RDP (2% vs. 10%, p = 0.042). The spleen preservation rate, defined as the proportion of cases in which spleen preservation was achieved preoperatively, was 100% (12/12) and 92% (23/25) in the RDP and LDP groups, respectively (p = 0.203). The splenic vessels preservation rate was significantly higher with RDP (100% [10/10]) than with LDP (67% [16/24]; p = 0.011). Postoperative complication rates did not differ significantly between the two groups. Conclusions Compared with LDP, RDP was associated with significantly reduced intraoperative blood loss, a lower conversion rate to open surgery, and a higher success rate in splenic vessels preservation, suggesting the technical advantages of RDP.
- 20 November 2025
- Published by Springer Nature in Surgery Today
- Vol. 56 (5) , 799-806
A comparison of laparoscopic and robotic distal pancreatectomy with spleen and Splenic vessels preservation: an intention-based evaluation in a single-center retrospective study
Purpose To compare the short-term outcomes of robotic distal pancreatectomy (RDP) and laparoscopic distal pancreatectomy (LDP), with a particular focus on the actual completion rates of spleen and splenic vessels preservation preoperatively. Methods Fifty-two RDP and 87 LDP procedures performed between 2014 and 2024 were retrospectively analyzed. Results The operative time was significantly longer for RDP than for LDP (median 407 min vs. 320 min, p < 0.0001), whereas the intraoperative blood loss was significantly lower (median 70 mL vs. 100 mL, p = 0.011). The rate of conversion to open surgery was also lower for RDP (2% vs. 10%, p = 0.042). The spleen preservation rate, defined as the proportion of cases in which spleen preservation was achieved preoperatively, was 100% (12/12) and 92% (23/25) in the RDP and LDP groups, respectively (p = 0.203). The splenic vessels preservation rate was significantly higher with RDP (100% [10/10]) than with LDP (67% [16/24]; p = 0.011). Postoperative complication rates did not differ significantly between the two groups. Conclusions Compared with LDP, RDP was associated with significantly reduced intraoperative blood loss, a lower conversion rate to open surgery, and a higher success rate in splenic vessels preservation, suggesting the technical advantages of RDP.
- 17 October 2025
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (1) , 100-105
Cefepime-induced encephalopathy following pancreaticoduodenectomy: a case report of a rare postoperative complication in gastrointestinal surgery
We report a rare case of cefepime-induced encephalopathy (CE) after pancreaticoduodenectomy. An 83-year-old female patient underwent pancreaticoduodenectomy for a distal bile duct tumor. On postoperative day (POD) 6, she developed a pseudoaneurysm secondary to postoperative pancreatic fistula, for which interventional radiology (IVR) treatment was performed. A liver abscess developed after IVR treatment on POD 15. Multidrug-resistant P. aeruginosa was detected in a drain culture, prompting a change of antibiotic therapy to cefepime on POD 30. Antifungal therapy was initiated for fungemia; however, her renal function progressively deteriorated. On POD 56, the patient presented with vomiting, expressionlessness, and hypokinesia. However, brain computed tomography revealed no abnormalities. Involuntary movement of upper and lower limbs were noted on POD 64, but both magnetic resonance imaging and cerebrospinal fluid examination showed none remarkably abnormalities. On POD 66, epileptic waves were detected via an electroencephalogram (EEG). CE was suspected, and cefepime administration was discontinued on POD 69. The involuntary movements disappeared promptly after cefepime discontinuation (POD 70). By POD 80, her communication ability improved, and EEG findings normalized. The patient was discharged on POD 260. Clinicians should consider CE in any patient receiving cefepime who presents with altered mental status and neurological symptoms.
- 17 October 2025
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 19 (1) , 100-105
Cefepime-induced encephalopathy following pancreaticoduodenectomy: a case report of a rare postoperative complication in gastrointestinal surgery
We report a rare case of cefepime-induced encephalopathy (CE) after pancreaticoduodenectomy. An 83-year-old female patient underwent pancreaticoduodenectomy for a distal bile duct tumor. On postoperative day (POD) 6, she developed a pseudoaneurysm secondary to postoperative pancreatic fistula, for which interventional radiology (IVR) treatment was performed. A liver abscess developed after IVR treatment on POD 15. Multidrug-resistant P. aeruginosa was detected in a drain culture, prompting a change of antibiotic therapy to cefepime on POD 30. Antifungal therapy was initiated for fungemia; however, her renal function progressively deteriorated. On POD 56, the patient presented with vomiting, expressionlessness, and hypokinesia. However, brain computed tomography revealed no abnormalities. Involuntary movement of upper and lower limbs were noted on POD 64, but both magnetic resonance imaging and cerebrospinal fluid examination showed none remarkably abnormalities. On POD 66, epileptic waves were detected via an electroencephalogram (EEG). CE was suspected, and cefepime administration was discontinued on POD 69. The involuntary movements disappeared promptly after cefepime discontinuation (POD 70). By POD 80, her communication ability improved, and EEG findings normalized. The patient was discharged on POD 260. Clinicians should consider CE in any patient receiving cefepime who presents with altered mental status and neurological symptoms.